产品说明
一般描述
Perphenazine is an antipsychotic drug used in treating schizophrenia. It modulates antioxidant levels and helps in the management of oxidative injury in schizophrenia. However, it is less effective than the clozapine drug group in improving response to oxidative injury.
包装
1, 5 g in glass bottle
生化/生理作用
D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro.
特点和优势
This compound was developed by Schering Plough. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
其他说明
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. P6402.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.
基本信息
| 经验(实验)分子式 | C21H26ClN3OS |
| 分子量 | 403.97 |
| EC 号 | 200-381-5 |
| MDL编号 | MFCD00056798 |
| PubChem化学物质编号 | 24278642 |
| NACRES | NA.77 |
产品性质
| 质量水平 | 200 |
| 创始人 | Schering Plough |
| 储存温度 | 2-8℃ |
| SMILES string | ClC(C=C1)=CC2=C1SC3=CC=CC=C3N2CCCN4CCN(CCO)CC4 |
| InChI | 1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2 |
| InChI key | RGCVKNLCSQQDEP-UHFFFAOYSA-N |
| Gene Information | human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152), DRD2(1813), OPRS1(10280) |
安全信息
| 象形图 |  |
| 警示用语： | Warning |
| 危险声明 | H302 - H317 |
| 预防措施声明 | P261 - P264 - P270 - P280 - P301 + P312 - P302 + P352 |
| 危险分类 | Acute Tox. 4 Oral - Skin Sens. 1 |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
